Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has opened a...
immuno-oncology
Numab Therapeutics AG (“Numab”) and Ono Pharmaceutical Co., Ltd. (“Ono”) today announced a global research, development and commercialization...
BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as “BioRay”) announced on October 7th that its clinical trial application for...
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products
![Synaffix ABL Bio Partnership](https://wellnessnews24.com/wp-content/uploads/2023/09/pexels-cottonbro-studio-3952241-720x530.jpg)
2 min read
Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development...